ATNM logo

Actinium Pharmaceuticals (ATNM)

Profile

Full Name

Actinium Pharmaceuticals, Inc.

Ticker Symbol

ATNM

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 27, 2012

Indexes

Not included

Website

http://www.actiniumpharma.com

Employees

37

Key Details

Price

$1.26(-3.08%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.27(+30.60% YoY)

PE ratio

-

Next earnings date

Apr 25, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.26
ATNM price is $1.26

30-Day Relative Volume

0.84
ATNM 30-day relative volume is 0.84

Price Performance

Price Today change

-3.08%
ATNM price is down -3.08% today

Price YTD change

0%
ATNM {parameterFullLabel} has remained unchanged since January 1st

Price 1-year change

-86%
ATNM price is down -86% year-on-year

Price 3-year change

-81.47%
ATNM price is down -81.47% over the past 3 years

Price Range

Price All-time high

$450.00
ATNM price is currently -99.72% below its historical high of $450.00

Price 3-year low

$1.03
ATNM price is currently +22.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$39.31M
ATNM market capitalization is $39.31 million

Market cap 3-year change

-73.9%
ATNM market capitalization is down -73.9% over the past 3 years

Market cap All-time high

$366.12M
ATNM market capitalization is currently -89.26% below its historical high of $366.12 million

Market cap sector rank

35.41%
ATNM market capitalization is higher than 35.41% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+6.12%
ATNM shares outstanding is up +6.12% year-on-year

Shares Outstanding 3-Year Change

+40.88%
ATNM shares outstanding is up +40.88% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.79
ATNM beta is 1.79

200-day SMA

$2.31
ATNM price is currently -45.49% below its 200-day simple moving average

50-day SMA

$1.27
ATNM price is currently -0.44% below its 50-day simple moving average

RSI

47.70
ATNM 14-day relative strength index is 47.70

Volume

0.84
ATNM 30-day relative volume is 0.84

ATR

$0.18
ATNM average true range is $0.18

10-day Historical Volatility

119.46%
ATNM 10-day historical volatility is 119.46%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ATNM annual revenue value is unknown

Revenue Analysts estimate

-
ATNM annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ATNM annual revenue 1-year change is unknown

Revenue Sector rank

-
ATNM annual revenue is unknown

EPS

EPS

-$1.27
ATNM annual earnings per share is -$1.27

EPS Analysts estimate

-$1.23
ATNM annual earnings per share is currently +3.25% higher than the consensus analysts' forecast

EPS 1-year change

+30.6%
ATNM annual earnings per share is up +30.6% year-on-year

EPS Sector rank

50.62%
ATNM annual earnings per share is higher than 50.62% of companies in Healthcare sector

Profit

Gross profit

-
ATNM annual gross profit value is unknown

Gross margin

-
ATNM annual gross profit margin value is unknown

Operating profit

-$42.12M
ATNM annual operating income is -$42.12 million

Operating margin

-
ATNM annual operating profit margin value is unknown

Net income

-$38.24M
ATNM annual net profit is -$38.24 million

Net margin

-
ATNM annual net profit margin value is unknown

Expenses

Total expenses

$42.12M
ATNM annual total expenses is $42.12 million

Operating expenses

$42.12M
ATNM annual total operating expenses is $42.12 million

Cost of goods sold

-
ATNM annual cost of goods sold value is unknown

Selling, general & administrative expenses

$12.08M
ATNM annual SGA is $12.08 million

Depreciation and amortization

$811.00K
ATNM annual depreciation & amortization is $811.00 thousand

Interest expense

-
ATNM annual interest expense value is unknown

Income tax

-
ATNM annual income tax value is unknown

EBIT & EBITDA

EBIT

-$42.12M
ATNM annual earnings before interest & taxes is -$42.12 million

EBITDA

-$41.31M
ATNM annual EBITDA is -$41.31 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$76.90M
ATNM annual total assets is $76.90 million

Non current assets

$2.39M
ATNM annual long term assets is $2.39 million

Current assets

$74.51M
ATNM annual total current assets is $74.51 million

Cash and cash equivalents

$72.90M
ATNM annual cash & cash equivalents is $72.90 million

Accounts receivable

-
ATNM annual accounts receivable value is unknown

Inventory

-
ATNM annual inventory value is unknown

Liabilities

Total liabilities

$44.14M
ATNM annual total liabilities is $44.14 million

Long term liabilities

$35.99M
ATNM annual total long term liabilities is $35.99 million

Current liabilities

$8.15M
ATNM annual total current liabilities is $8.15 million

Accounts payable

-
ATNM annual accounts payable value is unknown

Debt

Total debt

$1.57M
ATNM annual total debt is $1.57 million

Total debt 1-year change

-25.56%
ATNM annual total debt is down -25.56% year-on-year

Long term debt

$993.00K
ATNM annual long term debt is $993.00 thousand

Short term debt

$580.00K
ATNM annual short term debt is $580.00 thousand

Equity & Capital

Shareholders equity

$32.76M
ATNM annual stockholders equity is $32.76 million

Book value

$32.76M
ATNM annual book value is $32.76 million

Retained earnings

-$375.83M
ATNM annual retained earnings is -$375.83 million

Working capital

$66.36M
ATNM annual working capital is $66.36 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$33.07M
ATNM annual cash flow from operations is -$33.07 million

Cash from operations 1-year change

+30.13%
ATNM annual cash flow from operations is up +30.13% year-on-year

Cash from investing

-$11.00K
ATNM annual cash flow from investing activities is -$11.00 thousand

Cash from investing 1-year change

+92.81%
ATNM annual cash flow from investing activities is up +92.81% year-on-year

Cash from financing

$29.32M
ATNM annual cash flow from financing activities is $29.32 million

Cash from financing 1-year change

+97.18%
ATNM annual cash flow from financing activities is up +97.18% year-on-year

CAPEX

CAPEX

-
ATNM annual capital expenditures value is unknown

CAPEX 1-year change

-
ATNM annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$33.08M
ATNM annual free cash flow is -$33.08 million

Free cash flow 1-year change

+30.33%
ATNM annual free cash flow is up +30.33% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ATNM annual gross profit margin value is unknown

Operating margin

-
ATNM annual operating profit margin value is unknown

Net margin

-
ATNM annual net profit margin value is unknown

ROA & ROE

ROA

-49.73%
ATNM annual return on assets is -49.73%

ROE

-116.74%
ATNM annual return on equity is -116.74%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ATNM price to earnings ratio value is unknown

PE ratio Sector rank

-
ATNM price to earnings ratio is unknown

PB Ratio

PB ratio

1.20
ATNM price to book ratio is 1.20

PB ratio Sector rank

48.77%
ATNM price to book ratio is higher than 48.77% of companies in Healthcare sector

PS Ratio

PS ratio

-
ATNM price to sales ratio value is unknown

PS ratio Sector rank

-
ATNM price to sales ratio is unknown

Enterprise value

Enterprise value

-$32.02M
ATNM enterprise value is -$32.02 million

Enterprise value Sector rank

2.73%
ATNM enterprise value is higher than 2.73% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.78
ATNM EV/EBITDA is 0.78

EV/EBITDA Sector rank

74.02%
ATNM EV/EBITDA is higher than 74.02% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.14
ATNM annual current ratio is 9.14

Quick ratio

-
ATNM annual quick ratio value is unknown

Leverage

Debt to equity

0.05
ATNM annual debt to equity ratio is 0.05

Interest coverage ratio

-
ATNM annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ATNM piotroski f-score value is unknown

Altman Z-Score

-
ATNM altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Mar 27, 25 HC Wainwright & Co.
Buy
Mar 25, 25 HC Wainwright & Co.
Buy
Mar 20, 25 HC Wainwright & Co.
Buy
Mar 18, 25 HC Wainwright & Co.
Buy
Mar 11, 25 HC Wainwright & Co.
Buy
Nov 19, 24 Stephens & Co.
Overweight
Nov 15, 24 HC Wainwright & Co.
Buy
Aug 6, 24 Maxim Group
Buy
Aug 6, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

AADI logo
Aadi Bioscience (AADI)
CAMP logo
CAMP4 Therapeutics (CAMP)
ECOR logo
electroCore (ECOR)
ANEB logo
Anebulo Pharmaceuticals (ANEB)
MIST logo
Milestone Pharmaceuticals (MIST)
RANI logo
Rani Therapeutics Holdings (RANI)
IPSC logo
Century Therapeutics (IPSC)
DXR logo
Daxor (DXR)
Pheton Holdings Ltd Class A (PTHL)
  • What is the ticker symbol for Actinium Pharmaceuticals?
  • Does Actinium Pharmaceuticals pay dividends?
  • What sector is Actinium Pharmaceuticals in?
  • What industry is Actinium Pharmaceuticals in?
  • What country is Actinium Pharmaceuticals based in?
  • When did Actinium Pharmaceuticals go public?
  • Is Actinium Pharmaceuticals in the S&P 500?
  • Is Actinium Pharmaceuticals in the NASDAQ 100?
  • Is Actinium Pharmaceuticals in the Dow Jones?
  • When was Actinium Pharmaceuticals's last earnings report?
  • When does Actinium Pharmaceuticals report earnings?
  • Should I buy Actinium Pharmaceuticals stock now?

What is the ticker symbol for Actinium Pharmaceuticals?

The ticker symbol for Actinium Pharmaceuticals is NYSE American:ATNM

Does Actinium Pharmaceuticals pay dividends?

No, Actinium Pharmaceuticals does not pay dividends

What sector is Actinium Pharmaceuticals in?

Actinium Pharmaceuticals is in the Healthcare sector

What industry is Actinium Pharmaceuticals in?

Actinium Pharmaceuticals is in the Biotechnology industry

What country is Actinium Pharmaceuticals based in?

Actinium Pharmaceuticals is headquartered in United States

When did Actinium Pharmaceuticals go public?

Actinium Pharmaceuticals's initial public offering (IPO) was on December 27, 2012

Is Actinium Pharmaceuticals in the S&P 500?

No, Actinium Pharmaceuticals is not included in the S&P 500 index

Is Actinium Pharmaceuticals in the NASDAQ 100?

No, Actinium Pharmaceuticals is not included in the NASDAQ 100 index

Is Actinium Pharmaceuticals in the Dow Jones?

No, Actinium Pharmaceuticals is not included in the Dow Jones index

When was Actinium Pharmaceuticals's last earnings report?

Actinium Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does Actinium Pharmaceuticals report earnings?

The next expected earnings date for Actinium Pharmaceuticals is Apr 25, 2025

Should I buy Actinium Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page